Company profile: ARTMS
1.1 - Company Overview
Company description
- Provider of cyclotron-based technology for decentralized, local production of diagnostic imaging isotopes and purified radiopharmaceuticals. Offers the QUANTM Irradiation System (QIS) and QUANTM platforms for gallium-68, technetium-99m, zirconium-89, and copper-64, featuring automatic 2-way pneumatic transfer, a compact solid target station, and complete solid target processing solutions for PET and other clinical applications.
Products and services
- QUANTM Irradiation Systemâ„¢: Cyclotron-based, industrial-grade platform that decentralizes production of purified radiopharmaceuticals (68Ga, 89Zr, 99mTc, 64Cu) and integrates automatic 2-way pneumatic transfer, solid target station, complete solid target processing systems
- QUANTM-99 (Technetium-99m): Clinical-grade system that produces 99mTc, the most commonly used medical isotope for cardiac, neurologic, pulmonary, and other disease-state studies across diverse nuclear medicine applications
- QUANTM-68 (Gallium-68): PET-optimized platform that fabricates 68Ga for clinical PET imaging, including applications in neuroendocrine tumors and prostate cancer, enabling production of the radioisotope required for these diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ARTMS
Microban
HQ: United States
Website
- Description: Provider of unique antimicrobial solution design, delivering built-in antimicrobial protection and odor control technologies for consumer, industrial, and medical products globally. Solutions for polymers, textiles, and coatings include Ascera, AEGIS Microbe Shield, LapisShield, SilverShield, and continuous Microban Antimicrobial Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microban company profile →
Esperite
HQ: The Netherlands
Website
- Description: Provider of healthcare services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Esperite company profile →
DCN Diagnostics
HQ: United States
Website
- Description: Provider of lateral flow diagnostics development and manufacturing services, offering contract assay development across lateral flow, flow-through, dry chemistry, and microfluidic formats; design and integration of custom point-of-use readers and lab-on-a-chip systems; scalable manufacturing from clinical trials to commercialization; user-friendly sample collection devices and cartridges; and visual/fluorescent labeling and reporting solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCN Diagnostics company profile →
Tagarno
HQ: Denmark
Website
- Description: Provider of digital microscopes with 60 FPS, auto focus, and ergonomic design for specialists in materials science, agriculture, food, electronics, and forensics. Portfolio includes TREND for quality control with apps and accessories, FRONT for high-power inspections, MOVE and ZAP flexarm models, and ZIP for simple magnification and high-quality image capture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tagarno company profile →
Viventis Microscopy
HQ: Switzerland
Website
- Description: Provider of novel light sheet microscopy systems, including the Viventis LS2 Live light sheet fluorescence microscope with multi-view and multi-position imaging for detailed visualization of biological samples over time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viventis Microscopy company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ARTMS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ARTMS
2.2 - Growth funds investing in similar companies to ARTMS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ARTMS
4.2 - Public trading comparable groups for ARTMS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →